Average Ratings 0 Ratings
Average Ratings 0 Ratings
Description
Embark on a journey towards enhanced data integrity and assured decision-making with Clinical Ink. As trailblazers in the realm of eSource, their technological framework and service offerings ensure increased reliability from the initial source all the way to submission. Discover Lunexis™, a well-defined and interconnected eSource Ecosystem that provides targeted data capture solutions tailored to your protocol during the pivotal moments that count. The Lunexis platform simplifies the deployment of a cohesive and user-friendly eSource solution, granting you access to your study data anytime and anywhere. We offer more than just rapid and accurate data; we instill assurance in your processes. With this approach, both your sites and patients benefit from a smoother experience, leading to improved patient compliance and engagement, as well as ensuring proper protocol execution. Take the first step toward successfully managing your most intricate studies with confidence — utilize Lunexis to facilitate informed and optimal decision-making for your research endeavors. Moreover, this innovative platform not only streamlines processes but also enhances collaboration among all stakeholders involved in the study.
Description
Progressing artificial intelligence to remove the need for trial and error in healthcare, our digital twins facilitate swift and assured clinical trials. We focus on areas such as neuroscience, immunology, and metabolic diseases, among others. TwinRCTs expedite full enrollment by requiring fewer participants to provide equivalent statistical power compared to conventional trial methodologies. This approach significantly reduces the time needed for late-stage study enrollment. Additionally, TwinRCTs enhance the ability to detect treatment effects in early-stage studies by bolstering statistical power without necessitating an increase in participant numbers. They enable researchers to make informed decisions based on initial study outcomes and help attract more participants to trials. By utilizing smaller control groups, TwinRCTs also improve participants' odds of receiving the experimental treatment. Our commitment to positioning clinical trials with digital twins for regulatory success is unwavering. Unlearn is at the forefront of transforming the medical field through the innovative application of artificial intelligence, creating and implementing novel generative models that are trained on vast datasets derived from previous patient studies. This evolution in methodology not only streamlines research but also enhances the overall effectiveness of clinical trials.
API Access
Has API
API Access
Has API
Integrations
No details available.
Integrations
No details available.
Pricing Details
No price information available.
Free Trial
Free Version
Pricing Details
No price information available.
Free Trial
Free Version
Deployment
Web-Based
On-Premises
iPhone App
iPad App
Android App
Windows
Mac
Linux
Chromebook
Deployment
Web-Based
On-Premises
iPhone App
iPad App
Android App
Windows
Mac
Linux
Chromebook
Customer Support
Business Hours
Live Rep (24/7)
Online Support
Customer Support
Business Hours
Live Rep (24/7)
Online Support
Types of Training
Training Docs
Webinars
Live Training (Online)
In Person
Types of Training
Training Docs
Webinars
Live Training (Online)
In Person
Vendor Details
Company Name
Clinical Ink
Founded
2006
Country
United States
Website
www.clinicalink.com
Vendor Details
Company Name
Unlearn
Country
United States
Website
www.unlearn.ai/
Product Features
Clinical Trial Management
21 CFR Part 11 Compliance
Document Management
Electronic Data Capture
Enrollment Management
HIPAA Compliant
Monitoring
Patient Database
Recruiting Management
Scheduling
Study Planning
Product Features
Clinical Trial Management
21 CFR Part 11 Compliance
Document Management
Electronic Data Capture
Enrollment Management
HIPAA Compliant
Monitoring
Patient Database
Recruiting Management
Scheduling
Study Planning